158 related articles for article (PubMed ID: 15990318)
1. QSAR study on thiazole and thiadiazole analogues as antagonists for the adenosine A1 and A3 receptors.
Borghini A; Pietra D; Domenichelli P; Bianucci AM
Bioorg Med Chem; 2005 Sep; 13(18):5330-7. PubMed ID: 15990318
[TBL] [Abstract][Full Text] [Related]
2. QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists.
Massarelli I; Coi A; Pietra D; Nofal FA; Biagi G; Giorgi I; Leonardi M; Fiamingo F; Bianucci AM
Eur J Med Chem; 2008 Jan; 43(1):114-21. PubMed ID: 17418915
[TBL] [Abstract][Full Text] [Related]
3. Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques.
Bhattacharya P; Leonard JT; Roy K
Bioorg Med Chem; 2005 Feb; 13(4):1159-65. PubMed ID: 15670924
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.
van den Nieuwendijk AM; Pietra D; Heitman L; Göblyös A; IJzerman AP
J Med Chem; 2004 Jan; 47(3):663-72. PubMed ID: 14736246
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors.
Giorgi I; Leonardi M; Pietra D; Biagi G; Borghini A; Massarelli I; Ciampi O; Bianucci AM
Bioorg Med Chem; 2009 Mar; 17(5):1817-30. PubMed ID: 19230680
[TBL] [Abstract][Full Text] [Related]
6. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
[TBL] [Abstract][Full Text] [Related]
7. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
Manetti F; Schenone S; Bondavalli F; Brullo C; Bruno O; Ranise A; Mosti L; Menozzi G; Fossa P; Trincavelli ML; Martini C; Martinelli A; Tintori C; Botta M
J Med Chem; 2005 Nov; 48(23):7172-85. PubMed ID: 16279775
[TBL] [Abstract][Full Text] [Related]
9. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
Bhattacharya P; Leonard JT; Roy K
J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
[TBL] [Abstract][Full Text] [Related]
10. 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2004 Dec; 47(26):6529-40. PubMed ID: 15588088
[TBL] [Abstract][Full Text] [Related]
11. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists.
Cosimelli B; Greco G; Ehlardo M; Novellino E; Da Settimo F; Taliani S; La Motta C; Bellandi M; Tuccinardi T; Martinelli A; Ciampi O; Trincavelli ML; Martini C
J Med Chem; 2008 Mar; 51(6):1764-70. PubMed ID: 18269230
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
[TBL] [Abstract][Full Text] [Related]
14. Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.
Priego EM; Pérez-Pérez MJ; von Frijtag Drabbe Kuenzel JK; de Vries H; Ijzerman AP; Camarasa MJ; Martín-Santamaría S
ChemMedChem; 2008 Jan; 3(1):111-9. PubMed ID: 18000937
[TBL] [Abstract][Full Text] [Related]
15. 2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.
Biagi G; Bianucci AM; Coi A; Costa B; Fabbrini L; Giorgi I; Livi O; Micco I; Pacchini F; Santini E; Leonardi M; Nofal FA; Salerni OL; Scartoni V
Bioorg Med Chem; 2005 Aug; 13(15):4679-93. PubMed ID: 15908217
[TBL] [Abstract][Full Text] [Related]
16. Substituted 4-phenylthiazoles: Development of potent and selective A
Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
[TBL] [Abstract][Full Text] [Related]
18. QSAR study of N6-(substituted-phenylcarbamoyl) adenosine-5'-uronamides as agonist for A1 adenosine receptors.
Pérez González M; Terán Moldes Mdel C
Bull Math Biol; 2004 Jul; 66(4):907-20. PubMed ID: 15210326
[TBL] [Abstract][Full Text] [Related]
19. Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
González MP; Terán C; Teijeira M
Med Res Rev; 2008 May; 28(3):329-71. PubMed ID: 17668454
[TBL] [Abstract][Full Text] [Related]
20. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Calabri FR; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Deflorian F; Moro S
J Med Chem; 2004 Jul; 47(14):3580-90. PubMed ID: 15214785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
